Iodide

Iodide

SCHEMBL5088274

CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.58
▸ CHRNA7 P36544 9/20 0.47
▸ ALDH1A1 P00352 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ TRAP1 Q12931 2/20 0.44
▸ CSNK1E P49674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decyltriphenylphosphonium SCHEMBL3654788 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL10684637 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL5085133 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL2505241 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL3859955 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL5091833 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL5085194 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL6904643 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL2354963 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL298493 0.98 HIF1A (0.56) HIF1ACHRNA7ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2823709-A1 The use of ionic salts containing phosphonium cation Akademia im. Jana Dlugosza (PL) 2015-01-14 — — EP claimed
CN-110386855-B 1-halodiene and process for preparing it and (9E, 111Z) -9, 11-hexadecadienylacetate 信越化学工业株式会社 2023-03-28 — — CN disclosed
CN-111602087-B Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer and compound JSR株式会社 2023-03-24 — — CN disclosed
EP-3885334-B1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHINETSU CHEMICAL CO (JP) 2023-01-11 — — EP disclosed
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-23 — — US disclosed
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-30 — — US disclosed
EP-3885334-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 2021-09-29 — — EP disclosed
CN-113443971-A Method for producing alkynylalkoxymethyl ether compound and method for producing conjugated diene compound therefrom 信越化学工业株式会社 2021-09-28 — — CN disclosed
EP-3556742-B1 1-HALOALKADIENE AND PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9E,11Z)-9,11-HEXADECADIENYL ACETATE SHINETSU CHEMICAL CO (JP) 2021-07-14 — — EP disclosed
CN-111602087-A Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer and compound JSR株式会社 2020-08-28 — — CN disclosed
US-5340833-A Antiarthritic, antiinflammatory, antitumor agents EISAI CO., LTD. (JP) 1994-08-23 — — US disclosed
EP-0568289-A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors Eisai Co., Ltd. (JP) 1993-11-03 — — EP disclosed
US-5004822-A Isomers of 3-acetyl-2,2-dimethyl cyclopropane carboxylic acid derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1991-04-02 — — US disclosed
US-4622337-A INSECTICIDES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-11-11 — — US disclosed
US-4464391-A Pesticides NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-08-07 — — US disclosed
US-4343731-A Epoxy resin composition and process for production GENERAL ELECTRIC COMPANY (US) 1982-08-10 — — US disclosed
US-4320222-A PHOSPHONIUM HALIDE CATALYSTS AND POTASSIUM HYDROXIDE OR HALIDE SHELL OIL COMPANY (US) 1982-03-16 — — US disclosed
US-4118373-A Preparation of urethane elastomers from epoxy resin, polyols and polyisocyanates using a catalyst composition of an organometal salt with either nitrogen or phosphorus compounds THE DOW CHEMICAL COMPANY (US) 1978-10-03 — — US disclosed
US-4081491-A HEAT CURABLE SHELL OIL COMPANY (US) 1978-03-28 — — US disclosed
US-4027040-A ANALGESICS ROUSSEL-UCLAF (FR) 1977-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME ADH1C, ORC3, ADH1A HIF1A 2926/4885CHRNA7 505/4885ALDH1A1 18/4885
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same ADH1C, ORC3, ADH1A HIF1A 2926/4885CHRNA7 505/4885ALDH1A1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback